38 results on '"Standage, Stephen W."'
Search Results
2. Diagnostic Validation of the Updated Pediatric Sepsis Biomarker Risk II for Acute Kidney Injury Prediction Model in Pediatric Septic Shock*
- Author
-
Stanski, Natalja L., Zhang, Bin, Cvijanovich, Natalie Z., Fitzgerald, Julie C., Bigham, Michael T., Jain, Parag N., Schwarz, Adam J., Lutfi, Riad, Allen, Geoffrey L., Thomas, Neal J., Baines, Torrey, Haileselassie, Bereketeab, Weiss, Scott L., Atreya, Mihir R., Lautz, Andrew J., Zingarelli, Basilia, Standage, Stephen W., Kaplan, Jennifer, and Goldstein, Stuart L.
- Published
- 2024
- Full Text
- View/download PDF
3. External validation of the modified sepsis renal angina index for prediction of severe acute kidney injury in children with septic shock
- Author
-
Stanski, Natalja L., Basu, Rajit K., Cvijanovich, Natalie Z., Fitzgerald, Julie C., Bigham, Michael T., Jain, Parag N., Schwarz, Adam J., Lutfi, Riad, Thomas, Neal J., Baines, Torrey, Haileselassie, Bereketeab, Weiss, Scott L., Atreya, Mihir R., Lautz, Andrew J., Zingarelli, Basilia, Standage, Stephen W., Kaplan, Jennifer, Chawla, Lakhmir S., and Goldstein, Stuart L.
- Published
- 2023
- Full Text
- View/download PDF
4. Detrimental effects of PCSK9 loss-of-function in the pediatric host response to sepsis are mediated through independent influence on Angiopoietin-1
- Author
-
Atreya, Mihir R., Cvijanovich, Natalie Z., Fitzgerald, Julie C., Weiss, Scott L., Bigham, Michael T., Jain, Parag N., Schwarz, Adam J., Lutfi, Riad, Nowak, Jeffrey, Allen, Geoffrey L., Thomas, Neal J., Grunwell, Jocelyn R., Baines, Torrey, Quasney, Michael, Haileselassie, Bereketeab, Alder, Matthew N., Lahni, Patrick, Ripberger, Scarlett, Ekunwe, Adesuwa, Campbell, Kyle R., Walley, Keith R., and Standage, Stephen W.
- Published
- 2023
- Full Text
- View/download PDF
5. The application of omic technologies to research in sepsis-associated acute kidney injury
- Author
-
Hasson, Denise, Goldstein, Stuart L., and Standage, Stephen W.
- Subjects
Genomics -- Methods ,Proteomics -- Methods ,Acute renal failure -- Research -- Risk factors -- Development and progression ,Sepsis -- Research -- Complications and side effects -- Development and progression ,Pediatric research ,Metabolomics -- Methods ,Health - Abstract
Acute kidney injury (AKI) is common in critically ill children and adults, and sepsis-associated AKI (SA-AKI) is the most frequent cause of AKI in the ICU. To date, no mechanistically targeted therapeutic interventions have been identified. High-throughput 'omic' technologies (e.g., genomics, proteomics, metabolomics, etc.) offer a new angle of approach to achieve this end. In this review, we provide an update on the current understanding of SA-AKI pathophysiology. Omic technologies themselves are briefly discussed to facilitate interpretation of studies using them. We next summarize the body of SA-AKI research to date that has employed omic technologies. Importantly, omic studies are helping to elucidate a pathophysiology of SA-AKI centered around cellular stress responses, metabolic changes, and dysregulation of energy production that underlie its clinical features. Finally, we propose opportunities for future research using clinically relevant animal models, integrating multiple omic technologies and ultimately progressing to translational human studies focusing therapeutic strategies on targeted disease mechanisms., Author(s): Denise Hasson [sup.1] , Stuart L. Goldstein [sup.2] [sup.3] , Stephen W. Standage [sup.1] [sup.3] Author Affiliations: (1) grid.239573.9, 0000 0000 9025 8099, Division of Critical Care Medicine, Cincinnati [...]
- Published
- 2021
- Full Text
- View/download PDF
6. Hemophagocytic Lymphohistiocytosis Syndromes
- Author
-
Standage, Stephen W., Filipovich, Alexandra H., Wheeler, Derek S., editor, Wong, Hector R., editor, and Shanley, Thomas P., editor
- Published
- 2014
- Full Text
- View/download PDF
7. Detrimental effects of PCSK9 loss-of-function in the pediatric host response to sepsis are mediated through independent influence on Angiopoietin-1
- Author
-
Atreya, Mihir R., primary, Cvijanovich, Natalie Z., additional, Fitzgerald, Julie C., additional, Weiss, Scott L., additional, Bigham, Michael T., additional, Jain, Parag N., additional, Schwarz, Adam J., additional, Lutfi, Riad, additional, Nowak, Jeffrey, additional, Allen, Geoffrey L., additional, Thomas, Neal J., additional, Grunwell, Jocelyn R., additional, Baines, Torrey, additional, Quasney, Michael, additional, Haileselassie, Bereketeab, additional, Alder, Matthew N., additional, Lahni, Patrick, additional, Ripberger, Scarlett, additional, Ekunwe, Adesuwa, additional, Campbell, Kyle R., additional, Walley, Keith R., additional, and Standage, Stephen W., additional
- Published
- 2023
- Full Text
- View/download PDF
8. First-Time Use of the Seraph® 100 Microbind® Affinity Blood Filter in an Adolescent Patient with Severe COVID-19 Disease: A Case Report
- Author
-
Merrill, Kyle A., primary, Krallman, Kelli A., additional, Loeb, Daniel, additional, Standage, Stephen W., additional, Mattoon, Dawn, additional, Shan, Dandan, additional, Goldstein, Stuart L., additional, and Schuh, Meredith P., additional
- Published
- 2023
- Full Text
- View/download PDF
9. Choline supplementation attenuates experimental sepsis-associated acute kidney injury
- Author
-
Hasson, Denise C., primary, Watanabe-Chailland, Miki, additional, Romick-Rosendale, Lindsey, additional, Koterba, Adeleine, additional, Miner, Dashiell S., additional, Lahni, Patrick, additional, Ma, Qing, additional, Goldstein, Stuart L., additional, Devarajan, Prasad, additional, and Standage, Stephen W., additional
- Published
- 2022
- Full Text
- View/download PDF
10. First-Time Use of the Seraph® 100 Microbind® Affinity Blood Filter in an Adolescent Patient with Severe COVID-19 Disease: A Case Report.
- Author
-
Merrill, Kyle A., Krallman, Kelli A., Loeb, Daniel, Standage, Stephen W., Mattoon, Dawn, Shan, Dandan, Goldstein, Stuart L., and Schuh, Meredith P.
- Subjects
COVID-19 ,COVID-19 pandemic ,RENAL replacement therapy ,TEENAGERS ,RESPIRATORY insufficiency - Abstract
The Seraph
® 100 Microbind® Affinity Blood Filter (Seraph® 100) is a hemoperfusion device designed to adsorb bacteria, viruses, and toxins when added to extracorporeal circuits. The FDA granted emergency use authorization in adults, but this device had never been utilized in children. A 17-year-old patient with asthma presented with respiratory distress due to COVID-19. His course was complicated by respiratory failure, rhabdomyolysis, and stage 3 AKI requiring initiation of continuous kidney replacement therapy (CKRT) on ICU day 3. The Seraph® 100 filter was added on ICU day 4. He was treated with 3 filters from ICU day 4 to 8. On ICU day 8, he was extubated and CKRT discontinued. He required no further kidney replacement therapy but did not have laboratory work post-discharge. In conclusion, this adolescent patient with COVID-19 and AKI requiring CKRT tolerated treatment with the Seraph® 100 Microbind® Affinity Blood Filter without significant adverse events. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
11. Choline supplementation attenuates experimental sepsis-associated acute kidney injury.
- Author
-
Hasson, Denise C., Watanabe-Chailland, Miki, Romick-Rosendale, Lindsey, Koterba, Adeleine, Miner, Dashiell S., Lahni, Patrick, Qing Ma, Goldstein, Stuart L., Devarajan, Prasad, and Standage, Stephen W.
- Subjects
ACUTE kidney failure ,CRITICALLY ill children ,CHOLINE ,NEONATAL sepsis ,CARBON metabolism ,DIETARY supplements ,RENOVASCULAR hypertension - Abstract
Acute kidney injury (AKI) is common in critically ill patients, and sepsis is its leading cause. Sepsis-associated AKI (SA-AKI) causes greater morbidity and mortality than other AKI etiologies, yet the underlying mechanisms are incompletely understood. Metabolomic technologies can characterize cellular energy derangements, but few discovery analyses have evaluated the metabolomic profile of SA-AKI. To identify metabolic derangements amenable to therapeutic intervention, we assessed plasma and urine metabolites in septic mice and critically ill children and compared them by AKI status. Metabolites related to choline and central carbon metabolism were differentially abundant in SA-AKI in both mice and humans. Gene expression of enzymes related to choline metabolism was altered in the kidneys and liver of mice with SA-AKI. Treatment with intraperitoneal choline improved renal function in septic mice. Because pediatric patients with sepsis displayed similar metabolomic profiles to septic mice, choline supplementation may attenuate pediatric septic AKI. NEW & NOTEWORTHY Altered choline metabolism plays a role in both human and murine sepsis-associated acute kidney injury (SA-AKI), and choline administration in experimental SA-AKI improved renal function. These findings indicate that 1) mouse models can help interrogate clinically relevant mechanisms and 2) choline supplementation may ameliorate human SA-AKI. Future research will investigate clinically the impact of choline supplementation on human renal function in sepsis and, using model systems, how choline mediates its effects. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
12. Multi-Organ Transcriptome Dynamics in a Mouse Model of Cecal Ligation and Puncture-Induced Polymicrobial Sepsis
- Author
-
Rumienczyk, Izabela, primary, Kulecka, Maria, additional, Ostrowski, Jerzy, additional, Mar, Daniel, additional, Bomsztyk, Karol, additional, Standage, Stephen W, additional, and Mikula, Michal, additional
- Published
- 2021
- Full Text
- View/download PDF
13. Multi-Organ Transcriptome Dynamics in a Mouse Model of Cecal Ligation and Puncture-Induced Polymicrobial Sepsis
- Author
-
Rumienczyk,Izabela, Kulecka,Maria, Ostrowski,Jerzy, Mar,Daniel, Bomsztyk,Karol, Standage,Stephen W, Mikula,Michal, Rumienczyk,Izabela, Kulecka,Maria, Ostrowski,Jerzy, Mar,Daniel, Bomsztyk,Karol, Standage,Stephen W, and Mikula,Michal
- Abstract
Izabela Rumienczyk,1 Maria Kulecka,1,2 Jerzy Ostrowski,1,2 Daniel Mar,3 Karol Bomsztyk,3 Stephen W Standage,4,5 Michal Mikula1 1Maria Sklodowska-Curie National Research Institute of Oncology, Department of Genetics, Warsaw, 02-781, Poland; 2Centre for Postgraduate Medical Education, Department of Gastroenterology, Hepatology and Clinical Oncology, Warsaw, 01-813, Poland; 3UW Medicine South Lake Union, University of Washington, Seattle, WA, 98109, USA; 4Division of Critical Care Medicine, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA; 5Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USACorrespondence: Michal MikulaMaria Sklodowska-Curie National Research Institute of Oncology, Department of Genetics, Warsaw, 02-781, PolandTel +48225462655Email michal.mikula@pib-nio.plPurpose: During sepsis, an excessive inflammatory immune reaction contributes to multi-organ dysfunction syndrome (MODS), a critical condition associated with high morbidity and mortality; however, the molecular mechanisms driving MODS remain elusive.Methods: We used RNA sequencing to characterize transcriptional changes in the early phase of sepsis, at 6, 12, 24 hour time points in lung, kidney, liver, and heart tissues, in a cecal ligation and puncture (CLP)-induced polymicrobial sepsis murine model.Results: The CLP surgery induced significant changes (adj. p-value< 0.05) in expression of hundreds of transcripts in the four organs tested, with the highest number exceeding 2,000 differentially expressed genes (DEGs) in all organs at 12 hours post-CLP. Over-representation analysis by functional annotations of DEGs to the Reactome database revealed the immune system, hemostasis, lipid metabolism, signal transduction, and extracellular matrix remodeling biological processes as significantly altered in at least two organs, while metabolism of proteins and RNA were revelaed as being liver tissue specific in the early phase of sepsi
- Published
- 2021
14. NMR-based serum and urine metabolomic profile reveals suppression of mitochondrial pathways in experimental sepsis-associated acute kidney injury
- Author
-
Standage, Stephen W., primary, Xu, Shenyuan, additional, Brown, Lauren, additional, Ma, Qing, additional, Koterba, Adeleine, additional, Lahni, Patrick, additional, Devarajan, Prasad, additional, and Kennedy, Michael A., additional
- Published
- 2021
- Full Text
- View/download PDF
15. Duration of mechanical ventilation in life-threatening pediatric asthma: description of an acute asphyxial subgroup
- Author
-
Maffei, Frank A., van der Jagt, Elise W., Powers, Karen S., Standage, Stephen W., Connolly, Heidi V., Harmon, William G., Sullivan, John S., and Rubenstein, Jeffrey S.
- Subjects
Asphyxia -- Care and treatment ,Asthma in children -- Care and treatment - Abstract
Objective. Acute asphyxial asthma (AAA) is well described in adult patients and is characterized by a sudden onset that may rapidly progress to a near-arrest state. Despite the initial severity of AAA, mechanical ventilation often restores gas exchange promptly, resulting in shorter durations of ventilation. We believe that AAA can occur in children and can lead to respiratory failure that requires mechanical ventilation. Furthermore, children with rapid-onset respiratory failure that requires intubation in the emergency department (ED) are more likely to have AAA and a shorter duration of mechanical ventilation than those intubated in the pediatric intensive care unit (PICU). Methods. An 11-year retrospective chart review (1991-2002) was conducted of all children who were aged 2 through 18 years and had the primary diagnosis of status asthmaticus and required mechanical ventilation. Results. During the study period, 33 (11.4%) of 290 PICU admissions for status asthmaticus required mechanical ventilation. Thirteen children presented with rapid respiratory failure en route, on arrival, or within 30 minutes of arrival to the ED versus 20 children who progressed to respiratory failure later in their ED course or in the P|CU. Mean duration of mechanical ventilation was significantly shorter in the children who presented with rapid respiratory failure versus those with progressive respiratory failure (29 [+ or -] 43 hours vs 88 [+ or -] 72 hours). Children with rapid respiratory failure had greater improvements in ventilation and oxygenation than those with progressive respiratory failure as measured by pre-and postintubation changes in arterial carbon dioxide pressure, arterial oxygen pressure/fraction of inspired oxygen ratio, and alveolar-arterial gradient. According to site of intubation, 23 children required intubation in the ED, whereas 10 were intubated later in the PICU. Mean duration of mechanical ventilation was significantly shorter in the ED group versus the PICU group (42 [+ or -] 63 hours vs 118 [+ or -] 46 hours). There were significantly greater improvements in ventilation and oxygenation in the ED group versus the PICU group as measured by pre- and postintubation changes in arterial carbon dioxide pressure and arterial oxygen pressure/fraction of inspired oxygen ratio. Conclusions. AAA occurs in children and shares characteristics seen in adult counterparts. Need for early intubation is a marker for AAA and may not represent a failure to maximize preintubation therapies. AAA represents a distinct form of life-threatening asthma and requires additional study in children. Pediatrics 2004;114: 762-767; acute asphyxial asthma, rapid onset near-fatal asthma, respiratory failure, mechanical ventilation., ABBREVIATIONS. AAA, acute asphyxial asthma; GCHaS, Golisano Children's Hospital at Strong; PICU, pediatric intensive care unit; RRF, rapid respiratory failure; PRF, progressive respiratory failure; ED, emergency department; Pa[O.sub.2], arterial oxygen [...]
- Published
- 2004
16. Sepsis
- Author
-
Wong, Hector R., primary, Nowak, Jeffrey E., additional, Standage, Stephen W., additional, and Flauzino de Oliveira, Cláudio, additional
- Published
- 2011
- Full Text
- View/download PDF
17. Contributors
- Author
-
Ackerman, Veda L., primary, Adelson, P. David, additional, Agbeko, Rachel S., additional, Almodovar, Melvin C., additional, Alonso, Estella M., additional, Aneja, Raj K., additional, Angus, Derek C., additional, Argent, Andrew C., additional, Aspesberro, Francois P., additional, Bakar, Adnan M., additional, Bambach, Barbara, additional, Bass, Lee M., additional, Bayir, Hülya, additional, Beaulieu, Pierre, additional, Bell, Michael J., additional, Bender, M.A., additional, Benson, Jeffrey C., additional, Benton, Wade W., additional, Berg, Robert A., additional, Berkowitz, Darryl H., additional, Bhutta, Omar J., additional, Biagas, Katherine C., additional, Blatt, Julie, additional, Blowey, Douglas L., additional, Blumer, Jeffrey L., additional, Bradley, John S, additional, Brandom, Barbara W., additional, Brodsky, Linda, additional, Brogan, Thomas V., additional, Brothers, Adam W., additional, Bunchman, Timothy E., additional, Burd, Randall S., additional, Burns, Jeffrey, additional, Bush, Sean P., additional, Bystrak, Louis L., additional, Campbell, Angela J.P., additional, Cannavino, Christopher R., additional, Carcillo, Joseph A., additional, Carrillo-Lopez, Hector, additional, Cassara, Antonio, additional, Caty, Michael G., additional, Charpie, John R., additional, Chavez, Adrian, additional, Christenson, John C., additional, Clark, Jonna D., additional, Clark, Robert S.B., additional, Clement, Katherine C., additional, Coalson, Jacqueline J., additional, Coopersmith, Craig M., additional, Coppola, Christopher P., additional, Corey, Seth J., additional, Cox, Peter N., additional, Cummings, James J., additional, Curley, Martha A.Q., additional, Czosnyka, Marek, additional, D’Angelis, Christopher A., additional, Dahmer, Mary K., additional, Dalton, Heidi J., additional, Davis, Peter J., additional, Morena, M. Theresa de la, additional, Oliveira, Cláudio Flauzino de, additional, Dhanani, Sonny, additional, Dobyns, Emily L., additional, Donner, Elizabeth J., additional, Doughty, Lesley, additional, Dreyfuss, Didier, additional, Duncan, Christine, additional, Durand, Philippe, additional, Duthie, Susan, additional, Eigen, Howard, additional, Maamoun El-Dawy, Waleed M., additional, Elliott, Steven, additional, Emery, Helen M., additional, Escobar, Mauricio A., additional, Evans, Jacqueline M., additional, Felmet, Kate, additional, Fineman, Jeffrey R., additional, Fink, Ericka L., additional, Fiser, Richard T., additional, Fish, Frank A., additional, Fletcher, James E., additional, Forbes, Michael J., additional, Fort, Amber E., additional, Fost, Norman, additional, Frader, Joel E., additional, Franzon, Deborah E., additional, Fricker, F. Jay, additional, Friess, Stuart, additional, Fuhrman, Bradley P., additional, Garcia-Casal, Xiomara, additional, Gauvin, France, additional, Gaynor, J. William, additional, Gilad, Eli, additional, Gilbert, James C., additional, Glaser, Nicole S., additional, Goldstein, Stuart L., additional, Goodman, Denise M., additional, Graciano, Ana Lía, additional, Gunnarsson, Björn, additional, Hahn, Cecil D., additional, Hall, Mark, additional, Hamilton, Melinda Fiedor, additional, Han, Yong Y., additional, Hanson, Cherissa, additional, Harding, Cary O., additional, Hartman, Mary E., additional, Hazelzet, Jan A., additional, Heard, Christopher M.B., additional, Heine, Ann Marie, additional, Hernan, Lynn J., additional, Hertzig, Jeremy S., additional, Heulitt, Mark J., additional, Hoffman, Julien I.E., additional, Huhta, James C., additional, Ichord, Rebecca, additional, Inglis, Andrew, additional, Linggi Irby, Gretchen A., additional, Jacobs, Brian, additional, Jardine, David, additional, Jarillo-Quijada, Alberto, additional, Javouey, Etienne, additional, Jefferis Kirk, Christa C., additional, Johns, James A., additional, Joshi, Prashant, additional, Kagan, Richard J., additional, Kannankeril, Prince J., additional, Kanter, Robert K., additional, Karam, Oliver, additional, Kasten, Kevin R., additional, Kelly, Michael, additional, Khanna, Paritosh C., additional, Kochanek, Patrick M., additional, Kocis, Keith C., additional, Kocoshis, Samuel A., additional, Koves, Ildiko H., additional, Kulik, Thomas J., additional, Kumar, Vasanth H., additional, Lacroix, Jacques, additional, Lakshminrusimha, Satyan, additional, Langley, Joanne M., additional, Laussen, Peter C., additional, Levin, Daniel L., additional, Lewis-Newby, Mithya, additional, Lieh-Lai, Mary W., additional, Lindsey, Daphne, additional, Litalien, Catherine, additional, Lynch, Robert E., additional, Makley, Amy T., additional, Marcin, James P., additional, Mariscalco, Mary Michele, additional, Markovitz, Barry, additional, Martin, Lynn D., additional, Maxvold, Norma J., additional, Mazur, Paula M., additional, McArthur, Jennifer A., additional, McLaughlin, Jerry, additional, McLaughlin, Gwenn E., additional, Redwine, Karen McNiece, additional, Mehta, Nilesh M., additional, Mehta, Renuka, additional, Melvin, Ann J., additional, Menon, Sharad, additional, Mian, Ayesa N., additional, Michelson, Kelly, additional, Michienzi, Kelly A., additional, Moloney-Harmon, Patricia A., additional, Monagle, Paul, additional, Moss, Michele M., additional, Mou, Steven S., additional, Muenzer, Jared T., additional, Nadkarni, Vinay, additional, Nakagawa, Thomas A., additional, Naran, Navyn, additional, Nguyen, Trung, additional, Nicholson, Carol E., additional, Nielsen, Katie R., additional, Northway, Tracie, additional, Norwood, Victoria F., additional, Notterman, Daniel A., additional, Nowak, Jeffrey E., additional, Oishi, Peter, additional, Orr, Richard A., additional, Ouellette, Yves, additional, Parakininkas, Daiva, additional, Parker, Margaret M., additional, Pearson-Shaver, Tony, additional, Pérez Fontán, J. Julio, additional, Peters, Mark, additional, Pihoker, Catherine, additional, Pinsk, Maury N., additional, Pollack, Murray M., additional, Pon, Steven, additional, Quasney, Michael, additional, Rajasekaran, Surender, additional, Rampersad, Sally E., additional, Ranjit, Suchitra, additional, Reade, Erin P., additional, Reese Jr., James J., additional, Relvas, Monica, additional, Remy, Kenneth E., additional, Ricard, Jean-Damien, additional, Rice, Tom B., additional, Ridling, Debra Ann, additional, Roberts, Joan S., additional, Ross, Ashley S., additional, Roth, Kimberly R., additional, Rotta, Alexandre T., additional, Rowin, Mark E., additional, Roy, John, additional, Rubino, Christopher M., additional, Ruppel, Randall A., additional, Rushton, Cynda H., additional, Ryan, Rita M., additional, Salonia, Rosanne, additional, Salvin, Joshua, additional, Sanders Jr., Ronald C., additional, Sarnaik, Ajit A., additional, Sarnaik, Ashok P., additional, Saumon, Georges, additional, Sawin, Robert, additional, Scanlon, Matthew C., additional, Schenkman, Kenneth A., additional, Schexnayder, Stephen M., additional, Schleien, Charles L., additional, Schwartz, George J., additional, Schwartz, Steven M., additional, Shann, Frank, additional, Shaw, Dennis W.W., additional, Shemie, Sam D., additional, Shoykhet, Mish, additional, Sivarajan, V. Ben, additional, Skippen, Peter W., additional, Slonim, Anthony D., additional, Smith, Laurie, additional, Smith, Lincoln S., additional, Standage, Stephen W., additional, Steinberg, Joel B., additional, Steinhorn, David M., additional, Stojanovski, Sasko D., additional, Storm, Elizabeth A., additional, Stroud, Michael H., additional, Sturgill, Marc G., additional, Sutton, Robert M., additional, Symons, Jordan M., additional, Tailounie, Muayyad, additional, Talano, Julie-An, additional, Tamburro Jr., Robert, additional, Tasker, Robert C., additional, Thompson, Ann E., additional, Tilton, Ann H., additional, Tinmouth, Alan, additional, Tobias, Joseph D., additional, Tobin, Nicole H., additional, Todres, I. David, additional, Tucci, Marisa, additional, Ulate, Kalia P., additional, Valentine, Kevin M., additional, Vaughan, David J., additional, Venkataraman, Shekhar T., additional, Visoiu, Mihaela, additional, von Saint André–von Arnim, Amélie, additional, Wainwright, Mark S., additional, Wakeham, Martin K., additional, Watson, R. Scott, additional, Webb, Ashley N., additional, Weigle, Carl, additional, Weimer, Maria B., additional, Wessel, David L., additional, Wetzel, Randall C., additional, Wong, Hector R., additional, Wood, Ellen G., additional, Woolf, Alan D., additional, Woytash, James J., additional, Yanay, Ofer, additional, Zaritsky, Arno, additional, Zerr, Danielle M., additional, and Zimmerman, Jerry J., additional
- Published
- 2011
- Full Text
- View/download PDF
18. Biomarkers for pediatric sepsis and septic shock
- Author
-
Standage, Stephen W and Wong, Hector R
- Published
- 2011
- Full Text
- View/download PDF
19. The application of omic technologies to research in sepsis-associated acute kidney injury
- Author
-
Hasson, Denise, primary, Goldstein, Stuart L., additional, and Standage, Stephen W., additional
- Published
- 2020
- Full Text
- View/download PDF
20. PPARαcontributes to protection against metabolic and inflammatory derangements associated with acute kidney injury in experimental sepsis
- Author
-
Iwaki, Takuma, primary, Bennion, Brock G., additional, Stenson, Erin K., additional, Lynn, Jared C., additional, Otinga, Cynthia, additional, Djukovic, Danijel, additional, Raftery, Daniel, additional, Fei, Lin, additional, Wong, Hector R., additional, Liles, W. Conrad, additional, and Standage, Stephen W., additional
- Published
- 2019
- Full Text
- View/download PDF
21. NMR-based serum and urine metabolomic profile reveals suppression of mitochondrial pathways in experimental sepsis-associated acute kidney injury.
- Author
-
Standage, Stephen W., Xu, Shenyuan, Brown, Lauren, Ma, Qing, Koterba, Adeleine, Lahni, Patrick, Devarajan, Prasad, and Kennedy, Michael A.
- Abstract
Sepsis-associated acute kidney injury (SA-AKI) is a significant problem in the critically ill that causes increased death. Emerging understanding of this disease implicates metabolic dysfunction in its pathophysiology. This study sought to identify specific metabolic pathways amenable to potential therapeutic intervention. Using a murine model of sepsis, blood and tissue samples were collected for assessment of systemic inflammation, kidney function, and renal injury. Nuclear magnetic resonance (NMR)-based metabolomics quantified dozens of metabolites in serum and urine that were subsequently submitted to pathway analysis. Kidney tissue gene expression analysis confirmed the implicated pathways. Septic mice had elevated circulating levels of inflammatory cytokines and increased levels of blood urea nitrogen and creatinine, indicating both systemic inflammation and poor kidney function. Renal tissue showed only mild histological evidence of injury in sepsis. NMR metabolomic analysis identified the involvement of mitochondrial pathways associated with branched-chain amino acid metabolism, fatty acid oxidation, and de novo NAD+ biosynthesis in SA-AKI. Renal cortical gene expression of enzymes associated with those pathways was predominantly suppressed. Renal cortical fatty acid oxidation rates were lower in septic mice with high inflammation, and this correlated with higher serum creatinine levels. Similar to humans, septic mice demonstrated renal dysfunction without significant tissue disruption, pointing to metabolic derangement as an important contributor to SA-AKI pathophysiology. Metabolism of branchedchain amino acid and fatty acids and NAD+ synthesis, which all center on mitochondrial function, appeared to be suppressed. Developing interventions to activate these pathways may provide new therapeutic opportunities for SA-AKI. NEW & NOTEWORTHY NMR-based metabolomics revealed disruptions in branched-chain amino acid metabolism, fatty acid oxidation, and NAD+ synthesis in sepsis-associated acute kidney injury. These pathways represent essential processes for energy provision in renal tubular epithelial cells and may represent targetable mechanisms for therapeutic intervention. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
22. PPARα augments heart function and cardiac fatty acid oxidation in early experimental polymicrobial sepsis
- Author
-
Standage, Stephen W., primary, Bennion, Brock G., additional, Knowles, Taft O., additional, Ledee, Dolena R., additional, Portman, Michael A., additional, McGuire, John K., additional, Liles, W. Conrad, additional, and Olson, Aaron K., additional
- Published
- 2017
- Full Text
- View/download PDF
23. Nonhematopoietic Peroxisome Proliferator–Activated Receptor-α Protects Against Cardiac Injury and Enhances Survival in Experimental Polymicrobial Sepsis*
- Author
-
Standage, Stephen W., primary, Waworuntu, Rachel L., additional, Delaney, Martha A., additional, Maskal, Sara M., additional, Bennion, Brock G., additional, Duffield, Jeremy S., additional, Parks, William C., additional, Liles, W. Conrad, additional, and McGuire, John K., additional
- Published
- 2016
- Full Text
- View/download PDF
24. The Relationship Between KLF5 and PPARα in the Heart
- Author
-
Roe, Nathan D., primary, Standage, Stephen W., additional, and Tian, Rong, additional
- Published
- 2016
- Full Text
- View/download PDF
25. Reduced PPARα Expression is Associated with Decreased Survival and Increased Tissue Bacterial Load in Sepsis
- Author
-
Standage, Stephen W., Caldwell, Charles C., Zingarelli, Basilia, and Wong, Hector R.
- Subjects
Keratinocytes ,Male ,Mice, Knockout ,Time Factors ,Infant ,CD8-Positive T-Lymphocytes ,Models, Biological ,Article ,Mice ,Treatment Outcome ,Gene Expression Regulation ,Child, Preschool ,Sepsis ,Animals ,Cytokines ,Humans ,Female ,PPAR alpha ,Child ,Lung - Abstract
The peroxisome proliferator-activated receptor α (PPAR-α) is a member of the nuclear receptor family with many important physiologic roles related to metabolism and inflammation. Previous research in pediatric patients with septic shock revealed that genes corresponding to the PPAR-α signaling pathway are significantly downregulated in a subgroup of children with more severe disease. In this study, PPAR-α expression analysis using whole-blood derived RNA revealed that PPAR-α expression was decreased in patients with septic shock and that the magnitude of that decrement correlated with the severity of disease. In a mouse model of sepsis, induced by cecal ligation and puncture, knockout mice lacking PPAR-α had decreased survival compared with wild-type animals. Plasma cytokine analysis demonstrated decreased levels of interleukin 1β (IL-1β), IL-6, IL-17, keratinocyte-derived cytokine, macrophage chemoattractant protein 1, macrophage inflammatory protein 2, and tumor necrosis factor α at 24 h in PPAR-α knockout animals. Cell surface markers of activation on splenic dendritic cells, macrophages, and CD8 T cells were reduced in PPAR-α null animals, and the bacterial load in lung and splenic tissues was increased. These data indicate that reduced or absent PPAR-α expression confers a survival disadvantage in sepsis and that PPAR-α plays a role in maintaining appropriate immune functions during the sepsis response.
- Published
- 2012
26. Chapter 103 - Sepsis
- Author
-
Wong, Hector R., Nowak, Jeffrey E., Standage, Stephen W., and Flauzino de Oliveira, Cláudio
- Published
- 2011
- Full Text
- View/download PDF
27. High-Dose Rosuvastatin Treatment for Multifocal Stroke in Trauma-Induced Cerebral Fat Embolism Syndrome: A Case Report
- Author
-
Whalen, Lesta D., primary, Khot, Sandeep P., additional, and Standage, Stephen W., additional
- Published
- 2014
- Full Text
- View/download PDF
28. Reduced Peroxisome Proliferator-Activated Receptor α Expression Is Associated With Decreased Survival and Increased Tissue Bacterial Load in Sepsis
- Author
-
Standage, Stephen W., primary, Caldwell, Charles C., additional, Zingarelli, Basilia, additional, and Wong, Hector R., additional
- Published
- 2012
- Full Text
- View/download PDF
29. Identification of candidate serum biomarkers for severe septic shock-associated kidney injury via microarray
- Author
-
Basu, Rajit K, primary, Standage, Stephen W, additional, Cvijanovich, Natalie Z, additional, Allen, Geoffrey L, additional, Thomas, Neal J, additional, Freishtat, Robert J, additional, Anas, Nick, additional, Meyer, Keith, additional, Checchia, Paul A, additional, Lin, Richard, additional, Shanley, Thomas P, additional, Bigham, Michael T, additional, Wheeler, Derek S, additional, Devarajan, Prasad, additional, Goldstein, Stuart L, additional, and Wong, Hector R, additional
- Published
- 2011
- Full Text
- View/download PDF
30. Protection against sepsis-induced lung injury by selective inhibition of protein kinase C-δ (δ-PKC)
- Author
-
Kilpatrick, Laurie E, primary, Standage, Stephen W, additional, Li, Haiying, additional, Raj, Nichelle R, additional, Korchak, Helen M, additional, Wolfson, Marla R, additional, and Deutschman, Clifford S, additional
- Published
- 2010
- Full Text
- View/download PDF
31. Cerebrospinal fluid levels of extracellular heat shock protein 72: A potential biomarker for bacterial meningitis in children
- Author
-
Standage, Stephen W., Lahni, Patrick M., Ma, William, Kernie, Steven G., Wong, Hector R., and Wheeler, Derek S.
- Published
- 2014
- Full Text
- View/download PDF
32. Reduced Peroxisome Proliferator-Activated Receptor Expression Is Associated With Decreased Survival and Increased Tissue Bacterial Load in Sepsis
- Author
-
Standage, Stephen W., Caldwell, Charles C., Zingarelli, Basilia, and Wong, Hector R.
- Abstract
The peroxisome proliferator-activated receptor (PPAR-) is a member of the nuclear receptor family with many important physiologic roles related to metabolism and inflammation. Previous research in pediatric patients with septic shock revealed that genes corresponding to the PPAR- signaling pathway are significantly downregulated in a subgroup of children with more severe disease. In this study, PPAR- expression analysis using whole-blood derived RNA revealed that PPAR- expression was decreased in patients with septic shock and that the magnitude of that decrement correlated with the severity of disease. In a mouse model of sepsis, induced by cecal ligation and puncture, knockout mice lacking PPAR- had decreased survival compared with wild-type animals. Plasma cytokine analysis demonstrated decreased levels of interleukin 1 (IL-1), IL-6, IL-17, keratinocyte-derived cytokine, macrophage chemoattractant protein 1, macrophage inflammatory protein 2, and tumor necrosis factor at 24 h in PPAR- knockout animals. Cell surface markers of activation on splenic dendritic cells, macrophages, and CD8 T cells were reduced in PPAR- null animals, and the bacterial load in lung and splenic tissues was increased. These data indicate that reduced or absent PPAR- expression confers a survival disadvantage in sepsis and that PPAR- plays a role in maintaining appropriate immune functions during the sepsis response.
- Published
- 2012
- Full Text
- View/download PDF
33. Protection against sepsis‐induced lung injury by selective inhibition of protein kinase C‐δ (δ‐PKC)
- Author
-
Kilpatrick, Laurie E., Standage, Stephen W., Li, Haiying, Raj, Nichelle R., Korchak, Helen M., Wolfson, Marla R., and Deutschman, Clifford S.
- Abstract
Targeted inhibition of δ‐PKC exerted a lung‐protective effect and significantly attenuated pulmonary inflammatory cell infiltration, disruption of lung architecture, and pulmonary edema associated with sepsis. Inflammation and proinflammatory mediators are activators of δ‐PKC. In vitro, δ‐PKC regulates proinflammatory signaling in neutrophils and endothelial and epithelial cells, cells that can contribute to lung tissue damage associated with inflammation. In this study, a specific δ‐PKC TAT peptide inhibitor was used to test the hypothesis that inhibition of δ‐PKC would attenuate lung injury in an animal model of ARDS. Experimental ARDS was induced in rats via 2CLP, a model of polymicrobial sepsis. Following 2CLP surgery, the δ‐PKC TAT inhibitory peptide (2CLP+δ‐PKC TAT in PBS) or PBS (2CLP+PBS) was administered intratracheally. Controls consisted of SO, where animals underwent a laparotomy without 2CLP. Twenty‐four hours after SO or 2CLP, blood, BALF, and lung tissue were collected. 2CLP induced δ‐PKC phosphorylation in the lung within 24 h. Treatment with the δ‐PKC TAT inhibitory peptide significantly decreased pulmonary δ‐PKC phosphorylation, indicating effective inhibition of δ‐PKC activation. Plasma and BALF levels of the chemokines CINC‐1 and MIP‐2 were elevated in 2CLP + PBS rats as compared with SO rats. Treatment with δ‐PKC TAT reduced 2CLP‐induced elevations in chemokine levels in BALF and plasma, suggesting that δ‐PKC modulated chemokine expression. Most importantly, intratracheal administration of δ‐PKC TAT peptide significantly attenuated inflammatory cell infiltration, disruption of lung architecture, and pulmonary edema associated with 2CLP. Thus, δ‐PKC is an important regulator of proinflammatory events in the lung. Targeted inhibition of δ‐PKC exerted a lung‐protective effect 24 h after 2CLP.
- Published
- 2011
- Full Text
- View/download PDF
34. PPARα contributes to protection against metabolic and inflammatory derangements associated with acute kidney injury in experimental sepsis.
- Author
-
Iwaki, Takuma, Bennion, Brock G., Stenson, Erin K., Lynn, Jared C., Otinga, Cynthia, Djukovic, Danijel, Raftery, Daniel, Fei, Lin, Wong, Hector R., Liles, W. Conrad, and Standage, Stephen W.
- Subjects
CRITICALLY ill children ,PEROXISOME proliferator-activated receptors ,KIDNEY injuries ,SEPSIS ,FATTY acid oxidation - Abstract
Sepsis‐associated acute kidney injury (AKI) is a significant problem in critically ill children and adults resulting in increased morbidity and mortality. Fundamental mechanisms contributing to sepsis‐associated AKI are poorly understood. Previous research has demonstrated that peroxisome proliferator‐activated receptor α (PPARα) expression is associated with reduced organ system failure in sepsis. Using an experimental model of polymicrobial sepsis, we demonstrate that mice deficient in PPARα have worse kidney function, which is likely related to reduced fatty acid oxidation and increased inflammation. Ultrastructural evaluation with electron microscopy reveals that the proximal convoluted tubule is specifically injured in septic PPARα deficient mice. In this experimental group, serum metabolomic analysis reveals unanticipated metabolic derangements in tryptophan‐kynurenine‐NAD+ and pantothenate pathways. We also show that a subgroup of children with sepsis whose genome‐wide expression profiles are characterized by repression of the PPARα signaling pathway has increased incidence of severe AKI. These findings point toward interesting associations between sepsis‐associated AKI and PPARα‐driven fatty acid metabolism that merit further investigation. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
35. Derivation, validation, and transcriptomic assessment of pediatric septic shock phenotypes identified through latent profile analyses: Results from a prospective multi-center observational cohort.
- Author
-
Atreya MR, Huang M, Moore AR, Zheng H, Hasin-Brumshtein Y, Fitzgerald JC, Weiss SL, Cvijanovich NZ, Bigham MT, Jain PN, Schwarz AJ, Lutfi R, Nowak J, Thomas NJ, Quasney M, Dahmer MK, Baines T, Haileselassie B, Lautz AJ, Stanski NL, Standage SW, Kaplan JM, Zingarelli B, Sweeney TE, Khatri P, Sanchez-Pinto LN, and Kamaleswaran R
- Abstract
Background: Sepsis poses a grave threat, especially among children, but treatments are limited due to clinical and biological heterogeneity among patients. Thus, there is an urgent need for precise subclassification of patients to guide therapeutic interventions., Methods: We used clinical, laboratory, and biomarker data from a prospective multi-center pediatric septic shock cohort to derive phenotypes using latent profile analyses. Thereafter, we trained a support vector machine model to assign phenotypes in a hold-out validation set. We tested interactions between phenotypes and common sepsis therapies on clinical outcomes and conducted transcriptomic analyses to better understand the phenotype-specific biology. Finally, we compared whether newly identified phenotypes overlapped with established gene-expression endotypes and tested the utility of an integrated subclassification scheme., Findings: Among 1,071 patients included, we identified two phenotypes which we named 'inflamed' (19.5%) and an 'uninflamed' phenotype (80.5%). The 'inflamed' phenotype had an over 4-fold risk of 28-day mortality relative to those 'uninflamed'. Transcriptomic analysis revealed overexpression of genes implicated in the innate immune response and suggested an overabundance of developing neutrophils, pro-T/NK cells, and NK cells among those 'inflamed'. There was no significant overlap between endotypes and phenotypes. However, an integrated subclassification scheme demonstrated varying survival probabilities when comparing endophenotypes., Interpretation: Our research underscores the reproducibility of latent profile analyses to identify clinical and biologically informative pediatric septic shock phenotypes with high prognostic relevance. Pending validation, an integrated subclassification scheme, reflective of the different facets of the host response, holds promise to inform targeted intervention among those critically ill., Competing Interests: The authors declare the following competing interests: Cincinnati Children’s Hospital Medical Center (CCHMC) and the estate of the late Dr. Hector R. Wong hold patents for gene-expression-based pediatric septic shock endotypes, reflective of the host adaptive immune system. M.R.A and R.K hold a provisional patent for gene-expression-based multiple organ dysfunction syndrome (MODS) subclass identification, reflective of the innate immune response. Inflammatix is a for-profit company focusing on the development and commercialization of best-in-class host-response diagnostic tests. Y.H.B and T.E.S are employees and/or stockholders of Inflammatix Inc. P.K is a stockholder of Inflammatix Inc. The remaining authors have no conflicts of interest to disclose.
- Published
- 2023
- Full Text
- View/download PDF
36. Detrimental effects of PCSK9 loss-of-function in the pediatric host response to sepsis are mediated through independent influence on Angiopoietin-1.
- Author
-
Atreya MR, Cvijanovich NZ, Fitzgerald JC, Weiss SL, Bigham MT, Jain PN, Schwarz AJ, Lutfi R, Nowak J, Allen GL, Thomas NJ, Grunwell JR, Baines T, Quasney M, Haileselassie B, Alder MN, Lahni P, Ripberger S, Ekunwe A, Campbell KR, Walley KR, and Standage SW
- Abstract
Background: Sepsis is associated with significant mortality, yet there are no efficacious therapies beyond antibiotics and supportive care. In adult sepsis studies, PCSK9 loss-of-function (LOF) and inhibition has shown therapeutic promise, likely through enhanced low-density lipoprotein receptor (LDLR) mediated endotoxin clearance. In contrast, we previously demonstrated higher mortality in septic juvenile hosts with PCSK9 LOF. In addition to direct influence on serum lipoprotein levels, PCSK9 likely exerts pleiotropic effects on vascular endothelium. Both mechanisms may influence sepsis outcomes. We sought to test the influence of PCSK9 LOF genotype on endothelial dysfunction in pediatric sepsis. Methods: Secondary analyses of a prospective observational cohort of pediatric septic shock. Single nucleotide polymorphisms of PCSK9 and LDLR genes were assessed. Serum PCSK9, lipoprotein, and endothelial marker concentrations were measured. Multivariable linear regression tested the influence of PCSK9 LOF genotype on endothelial markers, adjusted for age, complicated course, and low- and high-density lipoproteins (LDL and HDL). Causal mediation analyses assessed impact of select endothelial markers on the association between PCSK9 LOF genotype and mortality. Juvenile Pcsk9 null and wildtype mice were subject to cecal slurry sepsis and endothelial markers were quantified. Results: 474 patients were included. PCSK9 LOF was associated with several markers of endothelial dysfunction, with strengthening of associations after exclusion of patients homozygous for the rs688 LDLR variant that renders it insensitive to PCSK9. Serum PCSK9 levels did not correlate with endothelial dysfunction. PCSK9 LOF significantly influenced concentrations of Angiopoietin-1 (Angpt-1) and Vascular Cell Adhesion Molecule-1 (VCAM-1). However, upon adjusting for LDL and HDL, PCSK9 LOF remained significantly associated with low Angpt-1 alone. Causal Mediation Analysis demonstrated that the effect of PCSK9 LOF on mortality was partially mediated by Angpt-1 (p=0.0008). Murine data corroborated these results with lower Angpt-1 and higher soluble thrombomodulin among knockout mice with sepsis relative to the wildtype. Conclusions: PCSK9 LOF independently influences serum Angpt-1 levels in pediatric septic shock. Angpt-1 likely contributes mechanistically to the effect of PCSK9 LOF on mortality in juvenile hosts. Mechanistic studies on the role of PCSK9-LDLR pathway on vascular homeostasis may lead to the development of novel pediatric-specific sepsis therapies.
- Published
- 2023
- Full Text
- View/download PDF
37. First-Time Use of the Seraph ® 100 Microbind ® Affinity Blood Filter in an Adolescent Patient with Severe COVID-19 Disease: A Case Report.
- Author
-
Merrill KA, Krallman KA, Loeb D, Standage SW, Mattoon D, Shan D, Goldstein SL, and Schuh MP
- Abstract
The Seraph
® 100 Microbind® Affinity Blood Filter (Seraph® 100) is a hemoperfusion device designed to adsorb bacteria, viruses, and toxins when added to extracorporeal circuits. The FDA granted emergency use authorization in adults, but this device had never been utilized in children. A 17-year-old patient with asthma presented with respiratory distress due to COVID-19. His course was complicated by respiratory failure, rhabdomyolysis, and stage 3 AKI requiring initiation of continuous kidney replacement therapy (CKRT) on ICU day 3. The Seraph® 100 filter was added on ICU day 4. He was treated with 3 filters from ICU day 4 to 8. On ICU day 8, he was extubated and CKRT discontinued. He required no further kidney replacement therapy but did not have laboratory work post-discharge. In conclusion, this adolescent patient with COVID-19 and AKI requiring CKRT tolerated treatment with the Seraph® 100 Microbind® Affinity Blood Filter without significant adverse events., Competing Interests: Stuart Goldstein serves on the Scientific Advisory Board for ExThera Medical Corporation who developed the Seraph® 100 Microbind® Affinity Blood Filter. Dawn Mattoon and Dandan Shan work for Quanterix Corporation who provided laboratory testing for COVID-19 N-protein and anti-spike IgG levels for authorship in this case report. Quanterix provided testing of patient serum for COVID 19 N-protein levels and COVID anti-spike IgG levels., (© 2023 The Author(s). Published by S. Karger AG, Basel.)- Published
- 2023
- Full Text
- View/download PDF
38. PPARα augments heart function and cardiac fatty acid oxidation in early experimental polymicrobial sepsis.
- Author
-
Standage SW, Bennion BG, Knowles TO, Ledee DR, Portman MA, McGuire JK, Liles WC, and Olson AK
- Subjects
- Animals, Blotting, Western, Carbon Isotopes, Cecum surgery, Citric Acid Cycle, Echocardiography, Immunoblotting, Isolated Heart Preparation, Ligation, Lipid Metabolism genetics, Magnetic Resonance Spectroscopy, Male, Mice, Mice, Knockout, Microscopy, Electron, Mitochondria, Heart metabolism, Mitochondria, Heart ultrastructure, Oxidation-Reduction, Punctures, Pyruvic Acid metabolism, Sepsis physiopathology, Ventricular Dysfunction, Left physiopathology, Fatty Acids metabolism, Myocardial Contraction, Myocardium metabolism, PPAR alpha genetics, Sepsis metabolism, Ventricular Dysfunction, Left genetics
- Abstract
Children with sepsis and multisystem organ failure have downregulated leukocyte gene expression of peroxisome proliferator-activated receptor-α (PPARα), a nuclear hormone receptor transcription factor that regulates inflammation and lipid metabolism. Mouse models of sepsis have likewise demonstrated that the absence of PPARα is associated with decreased survival and organ injury, specifically of the heart. Using a clinically relevant mouse model of early sepsis, we found that heart function increases in wild-type (WT) mice over the first 24 h of sepsis, but that mice lacking PPARα (Ppara
-/- ) cannot sustain the elevated heart function necessary to compensate for sepsis pathophysiology. Left ventricular shortening fraction, measured 24 h after initiation of sepsis by echocardiography, was higher in WT mice than in Ppara-/- mice. Ex vivo working heart studies demonstrated greater developed pressure, contractility, and aortic outflow in WT compared with Ppara-/- mice. Furthermore, cardiac fatty acid oxidation was increased in WT but not in Ppara-/- mice. Regulatory pathways controlling pyruvate incorporation into the citric acid cycle were inhibited by sepsis in both genotypes, but the regulatory state of enzymes controlling fatty acid oxidation appeared to be permissive in WT mice only. Mitochondrial ultrastructure was not altered in either genotype indicating that severe mitochondrial dysfunction is unlikely at this stage of sepsis. These data suggest that PPARα expression supports the hyperdynamic cardiac response early in the course of sepsis and that increased fatty acid oxidation may prevent morbidity and mortality., New & Noteworthy: In contrast to previous studies in septic shock using experimental mouse models, we are the first to demonstrate that heart function increases early in sepsis with an associated augmentation of cardiac fatty acid oxidation. Absence of peroxisome proliferator-activated receptor-α (PPARα) results in reduced cardiac performance and fatty acid oxidation in sepsis., (Copyright © 2017 the American Physiological Society.)- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.